Mitsubishi has acquired a 20% stake in Fujifilm's Fujifilm Diosynth Biotechnologies US and UK business units. Following the deal Mitsubishi and Fujifilm will jointly mange the two business units "to strongly promote the expansion of the biopharmaceutical contract manufacturing business". Fujifilm completed the acquisition of the business from Merck in April.
Fujifilm Diosynth Biologics
Tuesday, 28 June 2011
Fujifilm and Mitsubishi enter partnership
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment